- This event has passed.
The objectives of the Working Group meetings are to:
- Address the impact of menopause on women’s health, including associated symptoms, comorbidities, and stigma experienced by women undergoing the menopause transition
- Promote science-based health care policies around menopause to improve patient outcomes
- Participate in outreach opportunities to engage health care providers, employers, and policy leaders in discussions to improve care for perimenopausal and postmenopausal women
- Develop materials to expand education, raise awareness, and improve quality of life for women undergoing menopause
Working Group Participants
Omisade Burney-Scott, Founder and CEO, Black Girl’s Guide to Surviving Menopause
Pat M. Duckworth, MBA, BA, DipCHyp, NLP Master Prac, HPD, Therapist, Smarter Menopause
Jennifer E. Fairweather, DBA, Chief Human Resources Officer, Jefferson County
Stephanie S. Faubion, MD, MBA, FACP, NCMP, IF, Chair, Department of Medicine, Mayo Clinic, Jacksonville, Florida
Karen Giblin, President, Red Hot Mamas North America, Inc.
Claire Gill, Chief Executive Officer, Bone Health & Osteoporosis Foundation; Founder, National Menopause Foundation
Alicia A. Grandey, PhD, Liberal Arts Professor of Psychology, Pennsylvania State University
Claire Hardy, BSc, MSc, PhD, AFBPsS, C.Psychol, Senior Lecturer, Director of Research for the Division of Health Research, Lancaster University
Gavin Jack, PhD, Professor and Head, Department of Management, Monash Business School, Monash University
Donna Klassen, LCSW, Co-Founder, Let’s Talk Menopause; Therapist in Private Practice
Pamela Price, RN, Deputy Director; The Balm In Gilead, Inc; CEO, Priceless Enterprises Consulting, LLC
Lisa Satterfield, MS, MPH, CAE, CPH, Senior Director, Health Economics, American College of Obstetrics and Gynecology
Machelle (Mache) M. Seibel, MD, NCMP, Medical Director, Second Bloom Health, Faculty Beth Israel Hospital Harvard Medical School
Sharon Seibel, MD, Associate Editor, The Hot Years Magazine; Co-Author, Working Through Menopause
Support for this educational program has been provided by Astellas Pharma, Bayer, and Pfizer. SWHR maintains independence and editorial control over program development, content, and work products.